Promising therapy emerges for older patients with Hodgkin lymphoma A safe, effective first course of treatment has been identified for those who can’t or won't be treated with conventional combination chemotherapy.
Brentuximab vedotin, which delivers a potent dose of chemotherapy without harming healthy cells, delivers a high rate of remission in patients ages 60 and older, according to a study led by Andres Forero, M.D., published online in the journal Blood.
The next step is to evaluate this drug in combination with additional chemotherapy or immunotherapies that might prolong the response without relapse, Forero said.
UAB study uses smartphone technology to promote pulmonary rehab at home
Fueling game-changing ideas Nhabit Bush Hills combines community activism and computing to reduce the number of vacant houses in one Birmingham neighborhood. The project, started by UAB Collat School of Business Assistant Professor Anthony Hood, Ph.D., and his wife, Robin, earned Hood a Game Changer honor at the 2015 Vulcans Community Awards on Thursday.
The Hoods were able to launch NHabit Bush Hills thanks to the Community Health Innovation Awards, an annual grant competition from the UAB Center for Clinical and Translational Science. The awards have funded many creative solutions to public-health challenges in Birmingham neighborhoods, including a community carpentry project, fitness apps and gardens. Learn more in UAB Magazine.
Theatre UAB presents “Dancing at Lughnasa” Oct. 14-18
WBHM 90.3 FM's Fall Fund Drive Oct. 14-24
Melinda Barlow to speak on David Maisel’s “Black Maps” exhibition Oct. 15
Third annual “Autism: Unlocking the Mystery” conference Oct. 16
Soprano Kathleen Battle leads "Music from the Underground Railroad” Oct. 16
ASC presents GlobalFest
UAB Campus Calendar